Low AMH, High Hopes: Understanding DOR and Premature Ovarian Aging

When you hear terms like low AMH or diminished ovarian reserve (DOR), it can feel disheartening—especially for those actively trying to conceive. But at the Center for Human Reproduction (CHR), we believe that low numbers don’t have to mean lost hope. With the right diagnosis and a personalized treatment plan, many women with low ovarian reserve can still build the families they dream of. 

What Is Ovarian Reserve, and Why Does It Matter? 

Ovarian reserve refers to the number and quality of eggs a woman’s ovaries can produce. Naturally, OR declines with age, but some women experience this decline earlier than expected. This condition is known as diminished ovarian reserve or DOR. While aging is the most common reason for a drop in egg quality and quantity, DOR can also result from genetic factors, medical treatments, autoimmune conditions, or unexplained causes. 

Women with untreated DOR often have difficulty conceiving naturally and face higher miscarriage risks due to the crucial role egg quality plays in embryo development. At CHR, we’ve spent decades at the forefront of research on DOR—most notably pioneering the use of DHEA supplementation, which has become a standard treatment to help improve ovarian response. 

The Hidden Challenge: Premature Ovarian Aging (POA) 

For some women under 40, DOR is the result of premature ovarian aging (POA)—a condition first described by CHR researchers. POA occurs when the ovaries age faster than expected, leading to early fertility challenges even in women who appear otherwise healthy. These women may not show classic signs of POA and therefore are often misdiagnosed or dismissed because their age is mistakenly considered the culprit. 

Unlike premature ovarian failure (POF), where ovarian function stops entirely, women with POA still have viable eggs and a chance to conceive—especially with the right support. Treatments like DHEA or CoQ10, along with customized IVF protocols, have helped many women with POA at CHR to become parents. 

Diagnosing and Managing DOR and POA 

DOR and POA often present without obvious symptoms. In many cases, difficulty conceiving or repeated miscarriages are the first signs. Blood tests that measure AMH and FSH levels are the most reliable way to assess age-specific ovarian reserve. Elevated age-specific FSH and low AMH typically indicate diminished reserve, even if a woman is still having regular periods. 

While a diagnosis of DOR or POA can feel overwhelming, it does not have to be the end of the road. At CHR, we focus on early, accurate diagnosis and proactive care. For women at risk for premature decline, especially those with a family history or autoimmune conditions, early testing is key to preserving future fertility options. 

A Future Rooted in Research and Hope 

Whether your AMH levels are low, or you’re navigating the challenges of POA, you’re not alone—and you’re not without options. CHR’s research-driven, individualized approach to fertility care continues to offer hope to women often told they had none. At CHR, we believe in high hopes—even with low AMH.